ARCT
Arcturus Therapeutics Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.03
−5.32%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.67
- Revenue estimate
- $8.0M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.84
- EPS estimate
- -$1.00
- Revenue actual
- $3.0M
- Revenue estimate
- $3.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -56.7%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.00 | -$0.84 | Beat 15.70% | $3.0M |
| May 7, 2026 | -$1.01 | -$0.95 | Beat 5.94% | $2.1M |
| Mar 3, 2026 | -$0.92 | -$1.03 | Miss -11.96% | -$3.8M |
| Mar 6, 2025 | -$0.33 | -$1.11 | Miss -236.36% | $21.0M |
| Nov 7, 2024 | -$0.70 | -$0.26 | Beat 62.86% | $38.8M |
| Mar 7, 2024 | -$1.69 | -$0.32 | Beat 81.07% | $28.2M |
| Nov 14, 2023 | -$1.79 | -$0.61 | Beat 65.92% | $43.4M |
| Nov 9, 2022 | -$2.01 | -$1.33 | Beat 33.83% | $13.4M |
| Feb 28, 2022 | -$1.77 | -$1.47 | Beat 16.95% | $5.8M |
| Mar 1, 2021 | -$0.90 | -$1.25 | Miss -38.89% | $2.2M |
| May 7, 2020 | -$0.49 | -$0.67 | Miss -36.73% | $2.6M |
| Mar 11, 2020 | -$0.49 | -$0.76 | Miss -55.10% | $3.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026